pharma · Phenylketonuria · Achondroplasia
BioMarin Pharmaceutical Australia
BioMarin Pharmaceutical Australia Pty Ltd
BioMarin Pharmaceutical Australia clinical programs — 7 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 770 Lindaro Street, San Rafael, CA 94901, US
- Founded
- 1997
- Employees
- 3,171
- Programs
- 12
- Drugs
- 19
- Patents
- 12
BioMarin Pharmaceutical Australia projects
7 ClinicalTrials.gov programs sponsored by BioMarin Pharmaceutical Australia.
BioMarin Pharmaceutical Australia has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
111-302
BioMarin Pharmaceutical Australia Pty Ltd
Achondroplasia
1 trial -
111-303
BioMarin Pharmaceutical Australia Pty Ltd
Hypochondroplasia
1 trial -
111-308
BioMarin Pharmaceutical Australia Pty Ltd
Hypochondroplasia
1 trial -
333-301
BioMarin Pharmaceutical Australia Pty Ltd
Achondroplasia
1 trial -
BMN 111
BioMarin Pharmaceutical Australia Pty Ltd
Achondroplasia
6 trials -
BMN 333
BioMarin Pharmaceutical Australia Pty Ltd
Achondroplasia
1 trial -
Vosoritide
BioMarin Pharmaceutical Australia Pty Ltd
Hypochondroplasia
3 trials
Frequently asked questions
How many clinical projects does BioMarin Pharmaceutical Australia have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.